Evidence map›Paper›PMID 35522527›Full record

ArticleBioconjugate chemistry2022

One-Pot, One-Step Synthesis of Drug-Loaded Magnetic Multimicelle Aggregates.

Chang Soo Kim, Dmitry Nevozhay, Rebeca Romero Aburto, Ashok Pehere, Lan Pang, Rebecca Dillard, Ziqiu Wang, Clayton Smith, Kelsey Boitnott Mathieu, Marie Zhang and 3 more

Open access · greenAbstract read
In one paragraph

Article in Bioconjugate chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Stimuli-Responsive Materials for Biomedical Applications.Advanced materials (Deerfield Beach, Fla.) · 2025
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Chang Soo KimDepartment of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.
Dmitry NevozhayDepartment of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.
Rebeca Romero AburtoDepartment of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.
Ashok PehereDepartment of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.
Lan PangDepartment of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.
Rebecca DillardCenter for Molecular Microscopy, Frederick National Laboratory for Cancer Research, Center for Cancer Research, National Cancer Institute, NIH, Frederick, Maryland 21701, United States.
Ziqiu WangCenter for Molecular Microscopy, Frederick National Laboratory for Cancer Research, Center for Cancer Research, National Cancer Institute, NIH, Frederick, Maryland 21701, United States.
Clayton SmithCenter for Molecular Microscopy, Frederick National Laboratory for Cancer Research, Center for Cancer Research, National Cancer Institute, NIH, Frederick, Maryland 21701, United States.
Kelsey Boitnott MathieuDepartment of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.
Marie ZhangImagion Biosystems, Inc., San Diego, California 92121, United States.
John D HazleDepartment of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.
Robert C BastDepartment of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.
Konstantin SokolovDepartment of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.ORCID 0000-0002-0198-2005
The University of Texas MD Anderson Cancer Center · USCancer Research Center · US

Funding

Interdisciplinary Translational Pre/Postdoctoral Program in Cancer NanotechnologyT32CA196561 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Gang Bao, Konstantin V Sokolov · 2015 to 2026
$3.0M
NCI NIH HHS T32 CA196561
6 · The paper itself

Abstract

Lipid-based formulations provide a nanotechnology platform that is widely used in a variety of biomedical applications because it has several advantageous properties including biocompatibility, reduced toxicity, relative ease of surface modifications, and the possibility for efficient loading of drugs, biologics, and nanoparticles. A combination of lipid-based formulations with magnetic nanoparticles such as iron oxide was shown to be highly advantageous in a growing number of applications including magnet-mediated drug delivery and image-guided therapy. Currently, lipid-based formulations are prepared by multistep protocols. Simplification of the current multistep procedures can lead to a number of important technological advantages including significantly decreased processing time, higher reaction yield, better product reproducibility, and improved quality. Here, we introduce a one-pot, single-step synthesis of drug-loaded magnetic multimicelle aggregates (MaMAs), which is based on controlled flow infusion of an iron oxide nanoparticle/lipid mixture into an aqueous drug solution under ultrasonication. Furthermore, we prepared molecular-targeted MaMAs by directional antibody conjugation through an Fc moiety using Cu-free click chemistry. Fluorescence imaging and quantification confirmed that antibody-conjugated MaMAs showed high cell-specific targeting that was enhanced by magnetic delivery.

Indexed as

NanoparticlesDrug Delivery SystemsLipidsMagnetic PhenomenaPharmaceutical PreparationsReproducibility of ResultsLipidsPharmaceutical Preparations

Identifiers

PMID35522527
PMCPMC9121875
OpenAlexW4229011262

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.